Product Description
| Brand |
Snibe |
| Sample Type |
Serum/ Plasma |
| Pack Size |
100T |
| CAT No. |
130219008M |
| Application |
Infection |
The kit has been designed for the simultaneously qualitative determination of HIV-1 p24 antigen and antibodies to HIV-1, HIV-2 in human serum and plasma. The test has to be performed on MAGLUMI Fully-auto chemiluminescence immunoassay (CLIA) analyzer (Including Maglumi 600, Maglumi 800, Maglumi 1000, Maglumi 1000 Plus, Maglumi 2000, Maglumi 2000 Plus, Maglumi 4000, Maglumi 4000 Plus).
Efficient HIV Screening for Modern LaboratoriesEngineered for seamless integration with the MAGLUMI immunoassay analyzers, the HIV Ab/Ag Combi (CLIA) offers reliable detection in approximately 30-60 minutes per run. The kit's ready-to-use liquid reagents and automated processing reduce manual intervention, optimizing laboratory throughput. Supported by third-generation technology, this assay is ideal for large-scale screenings in clinical diagnostic settings.
High Accuracy and Safety ComplianceWith documented sensitivity and specificity above 99%, this CLIA kit ensures dependable results for screening HIV-1 p24 antigen and HIV-1/HIV-2 antibodies. The product complies with CE-IVD and ISO certification standards, confirming its quality and reliability. Integrated lot traceability and quality controls further ensure consistent, accurate performance across every lot.
Designed for User Convenience and TraceabilityThe kit provides pre-packaged, ready-to-use reagents along with calibrators and controls, minimizing setup time and error potential. Each component features barcode identification for direct analyzer compatibility and easy inventory management. The system is intended for use by trained personnel in diagnostics laboratories or hospitals, ensuring robust, traceable operation.
FAQ's of Snibe MAGLUMI HIV Ab/Ag Combi (CLIA):
Q: How is the Snibe MAGLUMI HIV Ab/Ag Combi (CLIA) test performed?
A: This assay is performed by loading serum or plasma samples onto a compatible MAGLUMI analyzer, which automates the process using the provided ready-to-use reagents. The analyzer detects HIV-1 p24 antigen and antibodies, providing qualitative results usually within 30-60 minutes.
Q: What are the advantages of using this kit for HIV screening?
A: The Snibe MAGLUMI HIV Ab/Ag Combi (CLIA) offers high sensitivity and specificity (>99%), automated workflow, and real-time operation on authorized analyzers. This enables rapid, reliable screening for early and combined HIV-1/2 detection, essential for clinical diagnosis.
Q: When should this HIV Ab/Ag combo test be used?
A: Use this kit when screening or diagnosing HIV infection in clinical laboratory settings, especially for timely identification of both the HIV-1 p24 antigen and antibodies to HIV-1 and HIV-2.
Q: Where can this product be utilized effectively?
A: The HIV Ab/Ag Combi (CLIA) kit is suitable for hospitals, diagnostic laboratories, and screening centers using MAGLUMI series immunoassay analyzers. It is not designed for point-of-care or home use.
Q: What controls are included to ensure accurate results?
A: Every kit includes lot-specific calibrators and controls for in-run quality assurance. Barcode identification and lot traceability help maintain consistent, reliable results with every batch.
Q: What are the storage requirements for the reagent kit?
A: Store the kit at 2-8C and avoid freezing the reagents. Stick to manufacturer's storage guidelines to preserve shelf life and maintain assay integrity.
Q: Is special preparation or handling required before using the reagents?
A: No special preparation is needed since all reagents are provided in a ready-to-use liquid form. Follow the instructions in the kit for proper loading and use to ensure optimal performance.